Q3 2024 Holdings
Filed 2024-11-14 | 81 holdings | $3.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Guardant Health Inc | NOTE11/1 | 40131MAB5 | $216.0M | $268,252,000 | 6.1% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $145.6M | $140,838,000 | 4.1% |
| Novocure LTD | NOTE11/0 | 67011XAB9 | $133.3M | $140,834,000 | 3.8% |
| CG Oncology Inc(CGON) | COM | 156944100 | $119.6M | 3,170,875 | 3.4% |
| Nuvasive Inc | NOTE 0.375% 3/1 | 670704AJ4 | $111.9M | $114,206,000 | 3.2% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $106.6M | 2,707,255 | 3.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $105.7M | 917,674 | 3.0% |
| Neogenomics Inc | NOTE 0.250% 1/1 | 64049MAB6 | $96.9M | $116,381,000 | 2.7% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $96.5M | 1,643,226 | 2.7% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $90.1M | 3,125,183 | 2.6% |
| Ironwood Pharmaceuticals Inc | NOTE 1.500% 6/1 | 46333XAH1 | $82.5M | $92,740,000 | 2.3% |
| Dexcom Inc | NOTE 0.375% 5/1 | 252131AM9 | $82.3M | $92,700,000 | 2.3% |
| Align Technology Inc(ALGN) | COM | 016255101 | $79.3M | 311,679 | 2.2% |
| Guardant Health Inc(GH) | COM | 40131M109 | $76.7M | 3,342,124 | 2.2% |
| Insulet Corp | NOTE 0.375% 9/0 | 45784PAK7 | $76.4M | $63,800,000 | 2.2% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $75.1M | 1,541,551 | 2.1% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $73.2M | 1,156,977 | 2.1% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $72.3M | 2,894,513 | 2.1% |
| Penumbra Inc(PEN) | COM | 70975L107 | $70.2M | 361,428 | 2.0% |
| Dexcom Inc | NOTE 0.250%11/1 | 252131AK3 | $70.1M | $73,500,000 | 2.0% |
| Maravai Lifesciences Hldgs I(MRVI) | COM CL A | 56600D107 | $69.4M | 8,353,287 | 2.0% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $67.9M | 4,873,853 | 1.9% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $64.4M | 2,189,836 | 1.8% |
| Repligen Corp(RGEN) | COM | 759916109 | $59.0M | 396,781 | 1.7% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $58.1M | 782,557 | 1.6% |
| Travere Therapeutics Inc | NOTE 2.500% 9/1 | 761299AB2 | $53.5M | $56,031,000 | 1.5% |
| Alphatec Hldgs Inc | NOTE 0.750% 8/0 | 02081GAB8 | $52.5M | $58,217,000 | 1.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $52.4M | 96,724 | 1.5% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $52.3M | 1,958,310 | 1.5% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $50.4M | 238,911 | 1.4% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $46.3M | 370,400 | 1.3% |
| Bridgebio Pharma Inc | NOTE 2.250% 2/0 | 10806XAD4 | $45.0M | $53,594,000 | 1.3% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $44.9M | 91,300 | 1.3% |
| Avadel Pharmaceuticals PLC | COM SHS | G29687103 | $44.4M | 3,388,939 | 1.3% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $42.2M | 1,657,600 | 1.2% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $41.1M | 707,240 | 1.2% |
| Glaukos Corp(GKOS) | COM | 377322102 | $40.6M | 311,616 | 1.2% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $39.0M | 183,818 | 1.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $34.0M | 297,568 | 1.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $33.7M | 3,070,837 | 1.0% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $31.6M | 1,284,472 | 0.9% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $30.7M | 168,691 | 0.9% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $30.0M | 1,107,770 | 0.9% |
| Dexcom Inc(DXCM) | COM | 252131107 | $29.6M | 441,086 | 0.8% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $29.4M | 247,750 | 0.8% |
| Paragon 28 Inc(FNAUSD) | COM | 69913P105 | $27.6M | 4,135,109 | 0.8% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $24.8M | 3,499,427 | 0.7% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $22.5M | 4,041,065 | 0.6% |
| Harrow Inc(HROW) | COM | 415858109 | $19.8M | 439,638 | 0.6% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $19.7M | 1,176,173 | 0.6% |